West Pharmaceutical Services, Inc.WSTNYSE
LOADING
|||
Operating Income Contraction
Trending lower, above historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$594.60M
↑ 36% above average
Average (9y)
$436.96M
Historical baseline
Range
High:$763.50M
Low:$125.70M
CAGR
+18.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $594.60M | -16.4% |
| 2023 | $710.90M | -6.9% |
| 2022 | $763.50M | +0.6% |
| 2021 | $758.70M | +81.1% |
| 2020 | $419.00M | +41.0% |
| 2019 | $297.20M | +16.6% |
| 2018 | $254.80M | +10.9% |
| 2017 | $229.70M | +6.6% |
| 2016 | $215.50M | +71.4% |
| 2015 | $125.70M | - |